StockWatch
·

Boston Bio Systems Ltd Q2 FY26 Results

BOSTONQ2 FY26 Results
Filing
MetricValue ( Cr)vs Q1 FY26
Revenue0.2435.6%
Total Income0.2435.6%
Expenditure0.1951.4%
PBT0.051.9%
Net Profit0.041.8%
OPM21.50%8.20pp
NPM16.10%6.12pp
EPS0.060.0%
View full financials

Informational and educational content only. Not investment advice.